Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Stem Cell Clinics Found Marketing in ClinicalTrials.gov

A review of entries in the U.S. government’s clinical trial registry shows commercial stem cell clinics are using the respected database to promote their services. . . . → Read More: Stem Cell Clinics Found Marketing in ClinicalTrials.gov

FDA Grants Priority Review for Gene Therapy

A biotechnology company making gene therapies to treat rare diseases says the Food and Drug Administration granted an accelerated review for its treatment of an inherited eye disorder. . . . → Read More: FDA Grants Priority Review for Gene Therapy

Report: Long, Complex Effort Needed to Stem Opioid Abuse

A report released today says years of coordinated public health efforts are needed at all levels to contain and reverse the current opioid abuse epidemic. . . . → Read More: Report: Long, Complex Effort Needed to Stem Opioid Abuse

Darpa Funding Research on Brain-Digital Implants

The advanced research agency in Department of Defense is supporting six new projects on neural devices that connect the brain to digital technologies to restore sensory functions. . . . → Read More: Darpa Funding Research on Brain-Digital Implants

FDA Approves Sickle Cell Drug

The Food and Drug Administration today approved a new drug that reduces the tendency for blood cells in people with sickle cell disease to stick together and block blood vessels. . . . → Read More: FDA Approves Sickle Cell Drug

Little Health Impact Found from Engineered Mosquitoes

An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans. . . . → Read More: Little Health Impact Found from Engineered Mosquitoes

Nerve Stimulation Approved for Children’s Epilepsy

The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old. . . . → Read More: Nerve Stimulation Approved for Children’s Epilepsy

FDA Approves Skin Infection Drug

The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics. . . . → Read More: FDA Approves Skin Infection Drug

FDA Developing Digital Device Certification Process

The U.S. Food and Drug Administration expects to unveil a new procedure for certifying digital medical devices that the agency says should speed their entry to the market. . . . → Read More: FDA Developing Digital Device Certification Process

Supreme Court Cuts Biosimilar Waiting Time

The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products. . . . → Read More: Supreme Court Cuts Biosimilar Waiting Time